Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 2/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 2/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21532481 | 0.99 | AKT1 (0.36) | AKT1ALOX5SMN1; SMN2HIF1AHSD11B1 | |
| SCHEMBL21532520 | 0.94 | ALOX5 (0.36) | AKT1ALOX5SMN1; SMN2HIF1AHSD11B1 | |
| SCHEMBL21532274 | 0.94 | SMN1; SMN2 (0.35) | AKT1SMN1; SMN2HIF1A | |
| SCHEMBL21532383 | 0.94 | AKT1 (0.32) | AKT1ALOX5PRKDC | |
| SCHEMBL21532522 | 0.93 | AKT1 (0.34) | AKT1ALOX5SMN1; SMN2HIF1AHSD11B1 | |
| SCHEMBL21532368 | 0.93 | ALOX5 (0.33) | AKT1ALOX5PRKDC | |
| SCHEMBL21532466 | 0.92 | AKT1 (0.34) | AKT1ALOX5SMN1; SMN2HIF1AHSD11B1 | |
| SCHEMBL23911751 | 0.91 | ALOX5 (0.34) | AKT1ALOX5SMN1; SMN2HIF1APRKDC | |
| SCHEMBL21532245 | 0.91 | ALOX5 (0.34) | AKT1ALOX5SMN1; SMN2HIF1APRKDC | |
| SCHEMBL21532549 | 0.91 | AKT1 (0.35) | AKT1ALOX5SMN1; SMN2HIF1AHSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11145825-B2 | Condensed cyclic compound and organic light-emitting device including i he same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-10-12 | — | — | US | disclosed |
| US-20190334095-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11145825-B2 | Condensed cyclic compound and organic light-emitting device including i he same | CRY1, CCNT1, CCNA1 | AKT1 2105/4885ALOX5 3170/4885SMN1; SMN2 2430/4885 |
| US-20190334095-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNT1, ARL1 | AKT1 2483/4885ALOX5 2800/4885SMN1; SMN2 2103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.